{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T19:10:05Z","timestamp":1748891405223,"version":"3.41.0"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.jpba.2025.116969","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T06:35:15Z","timestamp":1747204515000},"page":"116969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comprehensive study of degradation pathways and formation mechanism of major degradation impurities of gamithromycin active ingredient by UHPLC-HRMS and NMR"],"prefix":"10.1016","volume":"264","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-0432-7712","authenticated-orcid":false,"given":"Nayanthara U.","family":"Dharmaratne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abu M.","family":"Rustum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.116969_bib1","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/(SICI)1097-0231(19990830)13:16<1650::AID-RCM693>3.0.CO;2-8","article-title":"Structural elucidation studies of erythromycins by electrospray tandem mass spectrometry II","volume":"13","author":"Kearney","year":"1999","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2025.116969_bib2","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.3382\/ps.2012-02932","article-title":"Pharmacokinetics of gamithromycin after intravenous and subcutaneous administration in broiler chickens","volume":"92","author":"Watteyn","year":"2013","journal-title":"Poult. Sci."},{"key":"10.1016\/j.jpba.2025.116969_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01090","article-title":"Pharmacokinetics and pharmacodynamics of gamithromycin treatment of pasteurella multocida in a murine lung infection model","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jpba.2025.116969_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2885.2009.01125.x","article-title":"Pharmacokinetics of gamithromycin in cattle with comparison of plasma and lung tissue concentrations and plasma antibacterial activity","volume":"33","author":"Huang","year":"2009","journal-title":"J. Vet. Pharmacol. Ther."},{"key":"10.1016\/j.jpba.2025.116969_bib5","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/vms3.375","article-title":"Gamithromycin in swine: Pharmacokinetics and clinical evaluation against swine respiratory disease","volume":"7","author":"Hamel","year":"2021","journal-title":"Vet. Med. Sci."},{"key":"10.1016\/j.jpba.2025.116969_bib6","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.chroma.2015.04.022","article-title":"Development and validation of a liquid chromatography\u2013tandem mass spectrometry method for the quantitative determination of gamithromycin in animal plasma, lung tissue and pulmonary epithelial lining fluid","volume":"1398","author":"De Baere","year":"2015","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jpba.2025.116969_bib7","first-page":"378","article-title":"Determination of gamithromycin in an injection by ultra-performance liquid chromatography-tandem quadrupole-time-of-flight mass spectrometry","volume":"71","author":"Wu","year":"2016","journal-title":"Pharmazie"},{"key":"10.1016\/j.jpba.2025.116969_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2021.122637","article-title":"Determination of gamithromycin residues in eggs, milk and edible tissue of food-producing animals by solid phase extraction combined with ultrahigh-performance liquid chromatography-tandem mass spectrometry","volume":"1171","author":"Yan","year":"2021","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.jpba.2025.116969_bib9","unstructured":"L.. Y. and J.Q. Dexing, H; Jiao, W.: Zhikui Zhou, Qingguo Zhu, Jilei Shan, Wenwen Xia, Huajie Xu, Kaiying Li, Haojing Zang, Xinrong Qin, A method for determining related substances of gamithromycin, 2022."},{"year":"2003","series-title":"T. Guideline, International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Stability Testing of New Drug Substances and Products","author":"Harmonised","key":"10.1016\/j.jpba.2025.116969_bib10"},{"year":"2019","series-title":"International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products (VICH), 2019","author":"Agency","key":"10.1016\/j.jpba.2025.116969_bib11"},{"key":"10.1016\/j.jpba.2025.116969_bib12","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/(SICI)1097-0231(19990228)13:4<242::AID-RCM447>3.0.CO;2-B","article-title":"Structural elucidation studies of erythromycins by electrospray tandem mass spectrometry","volume":"13","author":"Gates","year":"1999","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2025.116969_bib13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jpba.2018.05.042","article-title":"pH-Dependent stability of azithromycin in aqueous solution and structure identification of two new degradation products","volume":"158","author":"Saita","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.116969_bib14","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1365\/s10337-009-1116-x","article-title":"Aspects of degradation kinetics of azithromycin in aqueous solution","volume":"70","author":"Zhang","year":"2009","journal-title":"Chromatographia"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525003103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525003103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T18:40:02Z","timestamp":1748889602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525003103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":14,"alternative-id":["S0731708525003103"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116969","relation":{},"ISSN":["0731-7085"],"issn-type":[{"type":"print","value":"0731-7085"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive study of degradation pathways and formation mechanism of major degradation impurities of gamithromycin active ingredient by UHPLC-HRMS and NMR","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.116969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116969"}}